Wedbush Morgan Maintains a 'Buy' on Dyax (DYAX); Comments on FDA Action
Tweet Send to a Friend
Wedbush Morgan maintains a 'Buy' on Dyax Corp. (Nasdaq: DYAX). Fair value $9.
Wedbush analyst says, "Dyax announced the FDA’s ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wedbush analyst says, "Dyax announced the FDA’s ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
